Literature DB >> 181912

A short-term quantitative XC assay for murine leukemia virus.

J W Gautsch, H Meier.   

Abstract

Entities:  

Mesh:

Year:  1976        PMID: 181912     DOI: 10.1016/0042-6822(76)90179-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  7 in total

1.  An internal deletion enhances the transcriptional activity of a recombinant retrovirus in hematopoietic cells in vivo.

Authors:  K L MacKenzie; L Bonham; G Symonds
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

2.  Evidence that retroviral transduction is mediated by DNA not by RNA.

Authors:  D W Goodrich; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

3.  Macromolecular requirements for abrogation of Fv-1 restriction by murine leukemia viruses.

Authors:  R H Bassin; B I Gerwin; J G Levin; G Duran-Troise; B M Benjers; A Rein
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

4.  Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines.

Authors:  L Q Sun; D Warrilow; L Wang; C Witherington; J Macpherson; G Symonds
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

5.  In vitro construction of a B-tropic virus by recombination: B-tropism is a cryptic phenotype of xenotropic murine retroviruses.

Authors:  J W Gautsch; J H Elder; F C Jensen; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

6.  Abrogation of Fv-1b restriction with murine leukemia viruses inactivated by heat or by gamma irradiation.

Authors:  R H Bassin; G Duran-Troise; B I Gerwin; A Rein
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

7.  Highly efficient induction of type C retroviruses by a human tumor in athymic mice.

Authors:  J W Gautsch; A F Knowles; F C Jensen; N O Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 12.779

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.